Periodic Reporting for period 1 - Alpha-Synuclein (Blocking the prion-like disease propagation in Parkinson’s disease and related disorders – model development and identification of cell-autonomous and cell non-autonomous factors.)

PROBLEM STATEMENTParkinson disease (PD) is the second most common neurodegenerative disease in populations aged 60 years or above. Current estimates indicate that the clinically diagnosed PD affects more than 6 million people worldwide, and presents a significant...